Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balance
Open Access
- 21 November 2011
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 42 (2) , 413-423
Abstract
Tumour necrosis factor alpha (TNF‐α) is a major inducer for inflammation and bone loss. Here, we investigated whether interleukin (IL)‐17 plays a role in TNF‐α‐mediated inflammation and bone resorption. Human TNF‐α transgenic (hTNFtg) mice were treated with a neutralizing anti‐IL‐17A antibody and assessed for inflammation, cartilage and bone damage. T‐cell transcription factors and lymphokine patterns were measured in the LNs. IL‐17A inhibition in the absence of IL‐1 was also evaluated by treating hTNFtg/IL‐1−/− mice with an IL‐17A neutralizing antibody. IL‐17A neutralization had only minor effects on TNF‐α‐induced inflammation but effectively reduced local and systemic bone loss by blocking osteoclast differentiation in vivo. Effects were based on a shift to bone‐protective T‐cell responses such as enhanced Th2 differentiation, IL‐4 and IL‐12 expression and Treg cell numbers. Whereas inflammation in hTNFtg/IL‐1−/− mice was highly sensitive to IL‐17A blockade, no shift in the T‐cell lineages and no additional benefit on bone mass were observed in response to IL‐17A neutralization. We thus conclude that IL‐17A is a key mediator of TNF‐α‐induced bone loss by closely interacting with IL‐1 in blocking bone protective T‐cell responses.Keywords
This publication has 47 references indexed in Scilit:
- The role of interleukin-17 in mediating joint destruction in rheumatoid arthritisBiochemical and Biophysical Research Communications, 2010
- Interleukin-1 is essential for systemic inflammatory bone lossAnnals of the Rheumatic Diseases, 2010
- Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-γ and counteraction by interferon-γArthritis Research & Therapy, 2009
- Osteoclasts and ArthritisJournal of Bone and Mineral Research, 2009
- IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated DiseaseThe Journal of Immunology, 2009
- TNF-induced structural joint damage is mediated by IL-1Proceedings of the National Academy of Sciences, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionJournal of Experimental Medicine, 2006
- Direct Three-Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and CalcaneusJournal of Bone and Mineral Research, 1999
- Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid SecretionJournal of Experimental Medicine, 1998